LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 3.11X leverage
Performance
- Low
- ₹472
- High
- ₹489
- 52 Week Low
- ₹464
- 52 Week High
- ₹818
- Open Price₹482
- Previous Close₹485
- Volume29,328
- 50 DMA₹497.64
- 100 DMA₹515.56
- 200 DMA₹544.94
Investment Returns
- Over 1 Month + 1.25%
- Over 3 Month -9.47%
- Over 6 Month -12.93%
- Over 1 Year -40.45%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12
- PEG Ratio
- -0.7
- Market Cap Cr
- 959
- P/B Ratio
- 1.3
- Average True Range
- 14
- EPS
- 39.94
- Dividend Yield
- 0.4
- MACD Signal
- -5.14
- RSI
- 43.96
- MFI
- 56.33
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹478.75
-6.25
(-1.29%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹485.58
- 50 Day
- ₹497.64
- 100 Day
- ₹515.56
- 200 Day
- ₹544.94
Resistance and Support
479.9
- R3 506.25
- R2 497.85
- R1 488.30
- S1 470.35
- S2 461.95
- S3 452.40
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹478 As on 13 January, 2026 | 22:54
The Market Cap of Lincoln Pharmaceuticals is ₹958.9 Cr As on 13 January, 2026 | 22:54
The P/E ratio of Lincoln Pharmaceuticals is 12 As on 13 January, 2026 | 22:54
The PB ratio of Lincoln Pharmaceuticals is 1.3 As on 13 January, 2026 | 22:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.